Search by Drug Name or NDC
NDC 55289-0344-90 Captopril 25 mg/1 Details
Captopril 25 mg/1
Captopril is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is CAPTOPRIL.
MedlinePlus Drug Summary
Captopril is used alone or in combination with other medications to treat high blood pressure and heart failure. It is also used to improve survival and reduce the risk of heart failure after a heart attack in patients a heart condition called left ventricular hypertrophy (enlargement of the walls of the left side of the heart). Captopril is also used to treat kidney disease (nephropathy) caused by diabetes in patients with type 1 diabetes and retinopathy (eye disease). Captopril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It decreases certain chemicals that tighten the blood vessels, so blood flows more smoothly and the heart can pump blood more efficiently. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 55289-0344-90Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Captopril
Product Information
| NDC | 55289-0344 |
|---|---|
| Product ID | 55289-344_05f3dd78-107a-6359-e063-6294a90a8a8a |
| Associated GPIs | 36100010000310 |
| GCN Sequence Number | 000380 |
| GCN Sequence Number Description | captopril TABLET 25 MG ORAL |
| HIC3 | A4D |
| HIC3 Description | ANTIHYPERTENSIVES, ACE INHIBITORS |
| GCN | 01481 |
| HICL Sequence Number | 000128 |
| HICL Sequence Number Description | CAPTOPRIL |
| Brand/Generic | Generic |
| Proprietary Name | Captopril |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Captopril |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | CAPTOPRIL |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA074505 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55289-0344-90 (55289034490)
| NDC Package Code | 55289-344-90 |
|---|---|
| Billing NDC | 55289034490 |
| Package | 90 TABLET in 1 BOTTLE, PLASTIC (55289-344-90) |
| Marketing Start Date | 2011-08-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |